close icon

Avoiding the 54% Crash in Brookfield Partners

When we last wrote about Brookfield Partners, the stock was hovering around $44 a share. That was on July 27th, 2019. Back then we though the price can reach $50, but instead of celebrating, the bulls should be getting ready to leave.

The reason for our skepticism wasn’t some special insight into the company’s operations that we had. Also, we had no idea what COVID-19 was back then. Instead, we focused on the Elliott Wave pattern in progress on BIP stock‘s weekly chart. Take a look below.

Ahead of the crash in Brookfield Partners stock

The pattern in question was, of course, a five-wave impulse. It had been unfolding since March 2009 and we labeled it 1-2-3-4-5. The last missing piece of the puzzle was a new high in wave 5. Wave 3 was slightly shorter than wave 1, so we thought wave 5 shouldn’t go much higher than $50.

How Not to Lose Half Your Money in Brookfield Partners

The theory states that a correction in the other direction follows every impulse. It made sense to expect a 40% drop to the support area of wave 4 near $32 or even lower. The ten months that followed were nothing short of a roller-coaster ride.

Brrokfield Partners survived the COVID-19 crash and is ready to climb again

Brookfield Partners kept climbing until February 2020, when it reached an all-time high of $50.61. Then the coronavirus pandemic caused a panic like no other. The stock fell to $23.16 by March 23rd for a 54% decline in total.

As of this writing, those who had the luck and courage to buy at the bottom are on the verge of doubling their money. On the other hand, those who ignored the impulse pattern and bought near $50 are still under water. That is the difference Elliott Wave analysis can make in investing.

Now, it looks like the bullish 5-3 wave cycle is complete. It is true that the correction was much faster and sharper than expected. However, the same could be said about Cigna in 2008. If this count is correct, new records are there for the taking in Brookfield Partners stock.

Similar Elliott Wave setups occur in the Forex, crypto and commodity markets, as well. Our Elliott Wave Video Course can teach you how to uncover them yourself!

Stay informed with our newsletter

Latest Elliott Wave analysis on different topics delivered to you weekly.

Privacy policy
You may also like:

DraftKings on the Verge of Another 40% Decline

It’s been almost three and a half months since we examined DraftKings stock in October, 2020. The share price was hovering near $57 after a strong run from $10.60 to over $64 in just several months. The regulatory environment in the U.S. seemed to be warming up and many analysts hurried to issue their BUY…

Read More »

AMN Healthcare Stock to Suffer a 2020-Like Drop

AMN Healthcare Services provides workforce and staffing solutions to healthcare facilities in the U.S. The company is relatively small with a market capitalization of less than $4 billion. However, small companies can make for excellent returns if one happens to identify the winners. And indeed, between late-2011 and early-2020, AMN stock from under $4 to…

Read More »

Zoetis Stock Getting Ahead of Itself, Invites Correction

Based in Parsippany, NJ, Zoetis Inc. is an animal medicine and vaccine developer and manufacturer. The company went public in 2013 and has been enjoying steady growth since. With the stock currently above $160 a share, Zoetis holds a market cap of nearly $80 billion. For a profitable and growing company like Zoetis, a rising…

Read More »

CBOE Stock Looking Good After a Record Year

CBOE Global Markets Inc. is an equities, options and futures exchange operator in the U.S. and Europe. The company traces its roots back to Chicago in 1973, when it practically invented options trading in its present form. CBOE is literally part of the very infrastructure of modern financial markets. So it is not surprising that…

Read More »

Novo Nordisk Bulls Have an Elliott Wave Problem

Novo Nordisk A/S is a Danish pharmaceuticals major with a market cap of over $160 billion. People need their medication even in recessions, so the company’s business wasn’t as affected by the 2020 crisis as most other industries. Novo Nordisk remains a top-notch pharma with consistent profits and revenue and no debt whatsoever. And the…

Read More »

Lockheed ‘s Correction Still Unfolding as Expected

Almost a year and a half ago, in July 2019, we wrote that Lockheed Martin is likely “setting the stage for an unpleasant surprise.” The stock had just reached a new all-time high and was trading at $370 a share. Optimism was in the air and analysts were more bullish than ever. An indeed, fundamentally,…

Read More »

Campari Bulls to Get a Serious Hangover Soon

Campari is an Italian liquor and spirits maker with traditions dating back to 1860. The company’s stock price plunged sharply in March along with the markets in general and then recovered just as quickly to new records by year-end. As shares hover near all-time highs, however, dark clouds appear to be gathering over the spirits…

Read More »

More analyses